XML 30 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Subsequent Events - Additional Information (Detail) - USD ($)
1 Months Ended
Apr. 01, 2019
May 23, 2019
May 23, 2019
Apr. 22, 2019
Apr. 23, 2019
Mar. 31, 2019
Dec. 31, 2018
Subsequent Event [Line Items]              
Convertible Preferred Stock, Terms of Conversion       Each share of Series A Preferred Stock is convertible into 1,000 shares of common stock and is eligible to vote on stockholder matters on an as-converted basis. The Series A Preferred Stock will convert into common stock upon the availability of a sufficient number of authorized shares of common stock.      
Proceeds from Issuance of Debt $ 540,000            
Common Stock, Shares, Issued           41,420,000 41,420,000
Preferred Stock, Shares Issued           0 0
Oncotelic [Member] | Series A Preferred Stock [Member]              
Subsequent Event [Line Items]              
Preferred Stock, Shares Issued       10,000      
Oncotelic [Member] | Common Stock [Member]              
Subsequent Event [Line Items]              
Common Stock, Shares, Issued       2,110,000      
Subsequent Event [Member]              
Subsequent Event [Line Items]              
Proceeds From Debt Issuance Retained By Company       $ 500,000      
Proceeds from Issuance of Debt     $ 540,000        
Debt Conversion, Converted Instrument, Shares Issued   700,000          
Subsequent Event [Member] | Bridge Financing [Member]              
Subsequent Event [Line Items]              
Debt Instrument Discount Percentage       10.00%      
Proceeds from Issuance of Debt   $ 540,000          
Debt Instrument, Convertible, Conversion Price   $ 0.10 $ 0.10        
Subsequent Event [Member] | Bridge Financing [Member] | Tranche One [Member]              
Subsequent Event [Line Items]              
Debt Instrument, Face Amount         $ 600,000    
Subsequent Event [Member] | Bridge Financing [Member] | Tranche Two [Member]              
Subsequent Event [Line Items]              
Debt Instrument, Face Amount   $ 600,000 $ 600,000        
Subsequent Event [Member] | Chief Executive Officer [Member] | Bridge Financing [Member]              
Subsequent Event [Line Items]              
Debt Instrument, Face Amount         $ 168,000    
Subsequent Event [Member] | Oncotelic [Member]              
Subsequent Event [Line Items]              
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares       41,000,000      
Subsequent Event [Member] | Oncotelic [Member] | Series A Preferred Stock [Member]              
Subsequent Event [Line Items]              
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares       193,713      
Subsequent Event [Member] | Oncotelic [Member] | Former Share Holders [Member]              
Subsequent Event [Line Items]              
Business Acquisition Percentage Of Ownership In Investee Before Transaction       85.00%      
Subsequent Event [Member] | Oncotelic [Member] | Other Share Holders [Member]              
Subsequent Event [Line Items]              
Business Acquisition Percentage Of Ownership In Investee Before Transaction       15.00%